Boscalid
- Generic Name
- Boscalid
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C18H12Cl2N2O
- CAS Number
- 188425-85-6
- Unique Ingredient Identifier
- 32MS8ZRD1V
- Background
Boscalid has been investigated for the treatment of OSDI, Glaucoma, Staining, Schirmers, and Disease Severity, among others.
- Associated Conditions
- -
- Associated Therapies
- -
Topical Cyclosporine and Disease Progression
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2007-12-05
- Last Posted Date
- 2008-09-25
- Lead Sponsor
- Innovative Medical
- Target Recruit Count
- 80
- Registration Number
- NCT00567983
- Locations
- 🇺🇸
Lakeside Eye Clinic, Chicago, Illinois, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath